Show
Sort by
-
- Journal Article
- A1
- open access
Does the impact of COVID‐19 on patients with systemic sclerosis change over time?
-
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products
-
Cohort enrichment strategies for progressive interstitial lung disease in systemic sclerosis From European Scleroderma Trials and Research
-
Cutaneous manifestations, clinical characteristics, and prognosis of patients with systemic sclerosis sine scleroderma : data from the International EUSTAR Database
-
- Journal Article
- A1
- open access
The burden of systemic sclerosis in Switzerland : the Swiss systemic sclerosis EUSTAR cohort
-
- Journal Article
- A1
- open access
Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis : an analysis from the EUSTAR database
-
- Journal Article
- A1
- open access
Phenotypes determined by cluster analysis and their survival in the prospective European Scleroderma Trials and Research cohort of patients with systemic sclerosis